Prognostic role of proliferating cell nuclear antigen in lung cancer: An immunohistochemical analysis

In Vivo

Volumn 12, Issue 1, 1998, Pages 85-88

  Caputi, Mario ^a   Esposito, Vincenzo ^a,b   Groger, Angela M ^b,c   Pacilio, Carmen ^a   Murabito, Marco ^c   Dekan, Gerhard ^c   Baldi, Feliciano ^a   Wolner, Ernst ^c   Giordano, Antonio ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cell cucle; Lung cancer; PCNA; Tumor suppressor

Indexed keywords

CYCLINE; DNA DIRECTED DNA POLYMERASE DELTA;

ARTICLE; DNA REPLICATION; EXCISION REPAIR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

EID: 0031965556     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pardee AB: G1 events and regulation of cell proliferation. Science 246: 60-608, 1989.
2. Murray AW, Kirschner MW: Dominoes and clocks: the union of two views of the cell cycle. Science 246: 614-621, 1989.
3. Fontanini G, Macchiarini P, Pepe S, ruggiero A, Hardin M, Bigini D, Vignati S, Pingitore R, Angeletti CA: The expression of Proliferating Cell Nuclear Antigen in paraffin sections of peripheral, node-negative, non small cell lung cancer.
4. Bravo R, Frank R, Blundell P, MacDonald-Bravo H: Cyclin PCNA is the auxiliary protein of DNA polymerase delta. Nature 520: 515-517, 1987.
5. Prelich G, Tan C, Kostura M: Functional identity of proliferating cell nuclear antigen and DNA polymerase delta auxiliary protein. Nature 326: 517-520, 1987.
6. Prelich G, Stillman B: Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 53: 117-126. 1988.
7. Duronio RJ, O'Farrell PH: Developmental control of a G1-S transcriptional program in Drosophila. Development 120: 1503-1515, 1994.
8. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication factor PCNA. Cell 71: 505-514, 1992.
9. Galand P, Degraef C: cyclin/Pcna immunostaining as alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22: 383-392, 1989.
10. Hall P A, Levinson D A, Woods A L, Yu C W, Kellock D B, Watkins J A, Barnes D M, Gillett C E, Camplejohn R, Dover R, Waseem N H, Lane D P: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with the evidence of deregulated expression in some neoplasms. J Pathol 62: 285-294, 1990.
11. Pelosi G, Zamboni G, Doglioni C, Rodella S, Bresaola E, Iacono C, Serio G, Iannucci A, Scarpa A: Immunodetection of proiferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 16: 1215-1225, 1992.
12. Esposito V, Baldi A., De Luca A., Paciocco G, Groger A, Sgaramella G, Claudio PP, giordano GG, Baldi F, Caputi M, Kaiser H, Giordano A: Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerations. Anticancer Res 17: 601-604, 1997.
13. Esposito V, Baldi A, De Luca A, Micheli P, Mazzarella G, Baldi F, Caputi M, Giordano A: Prognostic value of p53 in non small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking. Human Pathol 28: 233-237, 1997.
14. Ramael M, Jacobs W, Wejler J, Van Meerbeck J, Bialasiewicz P, Van De Bossche J, Buysse C, Vermeire P, Van Marck E: Proliferation in malignant mesothelioma determined by mitosis count and immunoreactivity for proliferating cell nuclear antigen (PCNA). J Pathol 172: 247-53, 1994.
15. Shonborn I, Zschiesche W, Minguillon C, Spitzer E, Mohner M, Ebeling K, Grosse R: Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopatological factors in breast cancer. J Canc Res Clin Oncol 121: 115-22, 1995.
16. Shottenfeld D: Epidemiology of lung cancer. In.Lung Cancer: Principles and Practice, ed. by Pass HI, Mitchell JB, Johnson, Turrisi AT. Lippincot-Raven Publishers, Philadelphia, 1996.
17. World Health Organization: Histological typing of lung tumors. 2nd ed., Geneva 25-26, 1981.
18. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ: Lung. In: Manual for staging of cancer. 4th ed. Chicago, American Joint Committee on Cancer 115-122, 1992.
19. Korkolopoulou P, Oates J, Crocker J, Edwards G: p53 expression in oat and non oat small cell lung carcinomas: correlation with proliferating cell nuclear antigen. J Clin Pathol 46: 1093-96 1993.
20. Oyama T, Mitsudomi T, Mizoue T, Oghami A, Osaki T, Nakanishi R, Yasumoto K: Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non small cell lung cancer. Surg Oncol 4: 83-89, 1995.